The efficacy of (99m)Tc-rituximab as a tracer for sentinel lymph node biopsy in cutaneous melanoma patients

BACKGROUND: The sentinel lymph node (SLN) status is a vital prognostic factor for malignant melanoma (MM) patients. There is increasing evidence that a radioactive agent, rather than its combination with blue dye, is sufficient for a SLN biopsy (SLNB). Thus, we discussed the efficacy of (99m)Tc-ritu...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jiayong, Tan, Zhichao, Xue, Ruifeng, Fan, Zhengfu, Bai, Chujie, Li, Shu, Gao, Tian, Zhang, Lu, Fang, Zhiwei, Si, Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848438/
https://www.ncbi.nlm.nih.gov/pubmed/35282108
http://dx.doi.org/10.21037/atm-21-6890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848438/
https://www.ncbi.nlm.nih.gov/pubmed/35282108
http://dx.doi.org/10.21037/atm-21-6890

Ejemplares similares